Form 4: Inari Medical Director Rebecca Chambers Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director Rebecca Chambers sold 260 shares of Inari Medical (NARI) at $45.99 per share on June 21, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On June 21, 2024, Rebecca Chambers, a director of Inari Medical, Inc. (NARI), sold 260 shares of common stock.
- The sale was executed at a price of $45.99 per share.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted on December 6, 2023.
- Following the transaction, Chambers directly owns 9,684 shares of Inari Medical common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company insiders, which is important for investors to monitor.
Stakeholder Impact
- The stock sale by a director could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2023-12-06 | Date the reporting person adopted a Rule 10b5-1 trading plan |
| 2024-06-21 | Date of the transaction (stock sale) |
| 2024-06-24 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.